38 results
8-K
PYXS
Pyxis Oncology Inc
10 Jun 24
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
7:56am
(the “Board”). The Board has determined that Mr. Metzger qualifies as an independent director under the corporate governance standards of The Nasdaq
8-K
wgth n2nvz
13 Mar 24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
4:31pm
8-K
ygh6i
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
424B3
fly th0zx8nsl0048ypw
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
821odsqjd6s
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
j5o2ov53uoa 02fqn
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
a0298t5m9rr3eiw js
24 May 23
Business combination disclosure
7:05am
425
ord1c
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
2ltwg8wpx1j
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
jhhbyjh1duobq
1 Nov 22
Shelf registration
4:51pm